Different electric field intensities may enhance the inhibitory effect of regorafenib on HCC cell lines by enhancing the normal interaction and transverse interaction between regorafenib and VEGFR2, including the proliferation, invasion, and metastasis of HCC cell lines. The gene discussed is KDR; the disease is hepatocellular carcinoma.